Margaret A Horn Revolution Medicines, Inc. (RVMD) insider trading activity

Margaret A Horn is Chief Operating Officer of Revolution Medicines, Inc.. Currently has a direct ownership of 141,053 shares of RVMD, which is worth approximately $9.56 Million. The most recent transaction as insider was on Sep 15, 2023, when has been sold 5,000 shares (Common Stock) at a price of $32.08 per share, resulting in proceeds of $160,400. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 141K

3.32% 3M change

10.21% 12M change

Total Value Held $9.56 Million

Margaret A Horn Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 15 2023	SELL Open market or private sale	$160,400 $32.08 p/Share	5,000 Reduced 4.79%	99,474 Common Stock
Sep 15 2023	BUY Exercise of conversion of derivative security	$20,450 $4.09 p/Share	5,000 Added 4.57%	104,474 Common Stock
Aug 31 2023	SELL Open market or private sale	$340,500 $34.05 p/Share	10,000 Reduced 9.13%	99,474 Common Stock
Aug 31 2023	BUY Exercise of conversion of derivative security	$40,900 $4.09 p/Share	10,000 Added 8.37%	109,474 Common Stock
Aug 15 2023	SELL Open market or private sale	$152,900 $30.58 p/Share	5,000 Reduced 4.79%	99,474 Common Stock
Aug 15 2023	BUY Exercise of conversion of derivative security	$20,450 $4.09 p/Share	5,000 Added 4.57%	104,474 Common Stock
Jun 20 2023	SELL Open market or private sale	$52,318 $24.89 p/Share	2,102 Reduced 2.07%	99,474 Common Stock

Mar 17 2023	SELL Open market or private sale	$26,789 $21.78 p/Share	1,230 Reduced 1.21%	100,062 Common Stock
Mar 01 2023	BUY Grant, award, or other acquisition	-	40,000 Added 28.31%	101,292 Common Stock
Dec 19 2022	SELL Open market or private sale	$27,986 $22.94 p/Share	1,220 Reduced 1.95%	61,292 Common Stock
Sep 19 2022	SELL Open market or private sale	$24,124 $19.04 p/Share	1,267 Reduced 1.99%	62,512 Common Stock
Jun 17 2022	SELL Open market or private sale	$20,324 $17.75 p/Share	1,145 Reduced 1.76%	63,779 Common Stock
Mar 17 2022	SELL Open market or private sale	$5,974 $18.61 p/Share	321 Reduced 0.5%	63,987 Common Stock
Mar 01 2022	BUY Grant, award, or other acquisition	-	38,800 Added 37.63%	64,308 Common Stock
Dec 17 2021	SELL Open market or private sale	$11,985 $24.41 p/Share	491 Reduced 1.89%	25,508 Common Stock
Sep 17 2021	SELL Open market or private sale	$14,380 $30.02 p/Share	479 Reduced 1.81%	25,999 Common Stock
Jun 17 2021	SELL Open market or private sale	$15,836 $34.13 p/Share	464 Reduced 1.72%	26,478 Common Stock
Mar 04 2021	BUY Grant, award, or other acquisition	-	15,000 Added 36.41%	26,198 Common Stock
Feb 05 2021	SELL Open market or private sale	$1,925,000 $55.0 p/Share	35,000 Reduced 75.76%	11,198 Common Stock
Feb 05 2021	BUY Exercise of conversion of derivative security	$165,550 $4.73 p/Share	35,000 Added 43.1%	46,198 Common Stock

Also insider at

SGMO

SANGAMO THERAPEUTICS, INC Healthcare

MAH

Margaret A Horn

Chief Operating Officer

Redwood City, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RVMD shares.

Notify only if

Value

Insider Trading

Get notified when an Revolution Medicines, Inc. insider buys or sells RVMD shares.

Notify only if

Operation

Value

Type

News

Receive news related to Revolution Medicines, Inc.

Track Activities on RVMD

Account